Goodwin Procter LLP advised Karuna Therapeutics, Inc. The Life Sciences team advised Karuna Therapeutics, Inc. (Nasdaq: KRTX) through its completion of underwritten public offering of 2,600,000…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now